Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability

To the Editor Zhou et al1 identify a clinically relevant comparative signal in radiotherapy-immunotherapy sequencing for patients with advanced non–small cell lung cancer (NSCLC) in their recent cohort study. My concern is specific to how that signal is summarized in the Key Points of the article.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2026-08-20
DOI
https://doi.org/10.1001/jamaoncol.2026.2915
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability

Chang Yue
JAMA Oncology
Cancer Immunotherapy and Biomarkers
article

Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability

Chang Yue
article en

Abstract

To the Editor Zhou et al1 identify a clinically relevant comparative signal in radiotherapy-immunotherapy sequencing for patients with advanced non–small cell lung cancer (NSCLC) in their recent cohort study. My concern is specific to how that signal is summarized in the Key Points of the article.

JAMA Oncology
Chengdu Medical College (CN)
Good health and well-being
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability — Chang Yue · JAMA Oncology (2026) | TGRS Research Map | TGRS